Bioactive Compounds List

Type Distribution
Max Phase Distribution
-
-

Bioactive Compounds List

Bio ID Target ID Target Name ChEMBL ID Name Type Max Phase Molecular Weight Targets Bioactivities Molecular Formula Details
bio1901 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL2028663 DABRAFENIB Small molecule Phase 4 519.57 334.0 420.0 C23H20F3N5O2S2 Details
bio1902 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL573352 TAS-106 Small molecule Phase 2 267.24 75.0 138.0 C11H13N3O5 Details
bio1903 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL4297908 CEVOSTAMAB Antibody Phase 2 -- -- -- -- Details
bio1904 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL312862 DEMECOLCINE Small molecule Phase 2 371.43 34.0 93.0 C21H25NO5 Details
bio1905 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL566 URACIL Small molecule Phase 3 112.09 77.0 100.0 C4H4N2O2 Details
bio1906 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL5095318 CREXAVIBART Antibody Phase 2 -- -- -- -- Details
bio1907 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL2104769 RACLOPRIDE C 11 Small molecule Phase 1 346.24 1.0 1.0 C15H20Cl2N2O3 Details
bio1908 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL324846 OCTANOIC ACID Small molecule Phase 2 144.21 35.0 70.0 C8H16O2 Details
bio1909 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL4297960 DAVANAT Unknown Phase 2 -- -- -- -- Details
bio1910 Tar11 Proto-oncogene c-RAF (c-RAF) CHEMBL2178579 ELUBRIXIN Small molecule Phase 2 463.32 5.0 16.0 C17H17Cl2FN4O4S Details